A randomized controlled trial of bacillus Calmette-Guerin and botulinum toxin-A for the treatment of refractory interstitial cystitis

UroToday International Journal

Volumn 2, Issue 1, 2009, Pages

  El Bahnasy, Abd Elhameed ^a   Farahat, Yasser A ^a   El Bendary, Mohamad ^a   Taha, Mohamad R ^a   El Damhogy, Mahmoud ^a   Mourad, Sherif ^b  

^a TANTA UNIVERSITY HOSPITAL   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Bacillus Calmette Guerin (BCG); Botulinum toxin (BTX A); Interstitial cystitis (IC)

Indexed keywords

EID: 61849173570     PISSN: None     EISSN: 19394810     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bladder Research Progress Review Group. Overcoming Bladder Disease: A Strategic Plan for Research. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health; 2002, Chapter 8. Available at: http://www.niddk.nih.gov/fund/ other/archivedconferences/2001/brprg_book.pdf. Accessed March 13, 2007.
2. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999 Feb;161(2):553-7.
3. Hunner GL. A rare type of bladder ulcer in women: Report of cases. Tans South Surg Gynecol Assoc. 1915;27:247.
4. Selo-Ojeme DO, Onwude JL. Interstitial cystitis. J Obstet Gynaecol. 2004 Apr;24(3):216-25.
5. Luo Y. A potential modality for interstitial cystitis; Intravesical use of anti-inflammatory peptide RDP 58. J Urol. 2005 Feb;173(2):340.
6. Zeidman EJ, Helfrick B, Pollard C, Thompson IM. Bacillus Calmette-Guerin immunotherapy for refractory interstitial cystitis. Urology. 1994 Jan;43(1):121-4.
7. Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, Culkin DJ, Diokno A, Hanno P, Landis JR, Madigan R, Messing EM, Nickel JC, Sant GR, Warren J, Wein AJ, Kusek JW, Nyberg LM, Foster HE; Interstitial Cystitis Clinical Trials Group. A randomized controlled trial of intravesical Bacillus Calmette-Guerin for treatment of refractory interstitial cystitis. J Urol. 2005 Apr;173(4):1186-91.
8. Kim DK, Thomas CA, Smith C, Chancellor MB. The case for bladder botulinum Toxin application. Urol Clin North Am. 2006 Nov;33(4):503-10, ix.
9. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity, muscle spasm and rigidity. Neurology. 1995 Apr;45(4):712-7.
10. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain. 2002 Nov-Dec; 18(6 Suppl):S177-81.
11. O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997 May;49(5A Suppl):58-63.
12. Peters KM, Diokno AC, Steinert BW. Preliminary study on urinary cytokine levels in interstitial cystitis: Does intravesical bacille Calmette-Guerin treat interstitial cystitis by altering the immune profile in the bladder? Urology. 1999 Sep;54(3):450-3.
13. Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N. The role of bladder afferent pathways in bladder hyperactivity induced by intravesical administration of nerve growth factor. J Urol. 2001 Mar;165(3):975-9.
14. Peters K, Diokno A, Steinert B, Yuhico M, Mitchell B, Krohta S, Gillette B, Gonzalez J. The efficacy of intravesical Tice strain baccilus Calmette-Guerin in the treatment of interstitial cystitis: A double-blind, prospective, placebo controlled trial. J Urol. 1997 Jun;157(6):2090-4.
15. Peters KM, Diokno AC, Steinert BW, Gonzalez JA. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: long term follow up. J Urol. 1998 May;159(5):1483-6; discussion 1486-7.
16. Hawthorn MH, Chapple CR, Cock M, Chess-Williams R. Urotheliu-derived inhibitory factor(s) influence detrusor muscle contractility in vitro. Br J Pharmacol. 2000 Feb;129(3):416-9.
17. Smith CP, Boone TB, de Groat WC, Chancellor MB, Somogyi GT. Effect of stimulation intensity and botulinum toxin isoform on rat bladder strip contractions. Brain Res Bull. 2003 Jul 15;61(2):165-71.
18. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology. 2004 Nov;64(5):871-5; discussion 875.
19. Kuo HC. Preliminary results of suburothelial injection of botulinum A toxin in the treatment of chronic interstitial cystitis. Urol Int. 2005;75(2):170-4.
20. Giannantoni A, Costantini E, Di Stasi SM, Tascini MC, Bini V, Porena M. Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: A pilot study. Eur Urol. 2006 Apr;49(4):704-9.
21. Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphencteric injection of Botulinum toxin type A. a treatment option for patients with chronic prostatic pain? Eur Urol. 2000 Oct;38(4):393-9.